Cargando…

Detection of Aggregation-Competent Tau in Neuron-Derived Extracellular Vesicles

Progressive cerebral accumulation of tau aggregates is a defining feature of Alzheimer’s disease (AD). A popular theory that seeks to explain the apparent spread of neurofibrillary tangle pathology proposes that aggregated tau is passed from neuron to neuron. Such a templated seeding process require...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guix, Francesc X., Corbett, Grant T., Cha, Diana J., Mustapic, Maja, Liu, Wen, Mengel, David, Chen, Zhicheng, Aikawa, Elena, Young-Pearse, Tracy, Kapogiannis, Dimitrios, Selkoe, Dennis J., Walsh, Dominic M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877524/ https://www.ncbi.nlm.nih.gov/pubmed/29495441 http://dx.doi.org/10.3390/ijms19030663

Ejemplares similares

miR-212 and miR-132 Are Downregulated in Neurally Derived Plasma Exosomes of Alzheimer’s Patients
por: Cha, Diana J., et al.
Publicado: (2019)

Plasma Extracellular Vesicles Enriched for Neuronal Origin: A Potential Window into Brain Pathologic Processes
por: Mustapic, Maja, et al.
Publicado: (2017)

Oral nicotinamide riboside raises NAD+ and lowers biomarkers of neurodegenerative pathology in plasma extracellular vesicles enriched for neuronal origin
por: Vreones, Michael, et al.
Publicado: (2022)

Novel Hominid-Specific IAPP Isoforms: Potential Biomarkers of Early Alzheimer’s Disease and Inhibitors of Amyloid Formation
por: Liu, Qing-Rong, et al.
Publicado: (2023)

Comparative assessment of Alzheimer’s disease-related biomarkers in plasma and neuron-derived extracellular vesicles: a nested case-control study
por: Manolopoulos, Apostolos, et al.
Publicado: (2023)

Inert and seed-competent tau monomers suggest structural origins of aggregation
por: Mirbaha, Hilda, et al.
Publicado: (2018)

Dynamics of plasma biomarkers in Down syndrome: the relative levels of Aβ42 decrease with age, whereas NT1 tau and NfL increase
por: Mengel, David, et al.
Publicado: (2020)

Mitochondrial RNA in Alzheimer’s Disease Circulating Extracellular Vesicles
por: Kim, Kyoung Mi, et al.
Publicado: (2020)

In a randomized trial in prostate cancer patients, dietary protein restriction modifies markers of leptin and insulin signaling in plasma extracellular vesicles
por: Eitan, Erez, et al.
Publicado: (2017)

Fully co-factor-free ClearTau platform produces seeding-competent Tau fibrils for reconstructing pathological Tau aggregates
por: Limorenko, Galina, et al.
Publicado: (2023)

Empagliflozin Induced Ketosis, Upregulated IGF-1/Insulin Receptors and the Canonical Insulin Signaling Pathway in Neurons, and Decreased the Excitatory Neurotransmitter Glutamate in the Brain of Non-Diabetics
por: Avgerinos, Konstantinos I., et al.
Publicado: (2022)

Extracellular vesicle-associated Aβ mediates trans-neuronal bioenergetic and Ca(2+)-handling deficits in Alzheimer’s disease models
por: Eitan, Erez, et al.
Publicado: (2016)

Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in murine Alzheimer’s disease
por: Tallon, Carolyn, et al.
Publicado: (2023)

Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in an Alzheimer’s disease mouse model
por: Tallon, Carolyn, et al.
Publicado: (2023)

Co-factor-free aggregation of tau into seeding-competent RNA-sequestering amyloid fibrils
por: Chakraborty, Pijush, et al.
Publicado: (2021)

Suppressing Tau Aggregation and Toxicity by an Anti-Aggregant Tau Fragment
por: Pir, Ghulam Jeelani, et al.
Publicado: (2018)

Anterograde and Retrograde Propagation of Inoculated Human Tau Fibrils and Tau Oligomers in a Non-Transgenic Rat Tauopathy Model
por: Langer Horvat, Lea, et al.
Publicado: (2023)

Propagation of Tau aggregates
por: Goedert, Michel, et al.
Publicado: (2017)

Insulin Resistance as a Link between Amyloid-Beta and Tau Pathologies in Alzheimer’s Disease
por: Mullins, Roger J., et al.
Publicado: (2017)

Low neural exosomal levels of cellular survival factors in Alzheimer’s disease
por: Goetzl, Edward J, et al.
Publicado: (2015)

PrP is a central player in toxicity mediated by soluble aggregates of neurodegeneration-causing proteins
por: Corbett, Grant T., et al.
Publicado: (2019)

Annexin A1–dependent tethering promotes extracellular vesicle aggregation revealed with single–extracellular vesicle analysis
por: Rogers, Maximillian A., et al.
Publicado: (2020)

EGCG impedes human Tau aggregation and interacts with Tau
por: Sonawane, Shweta Kishor, et al.
Publicado: (2020)

Target engagement in an alzheimer trial: Crenezumab lowers amyloid β oligomers in cerebrospinal fluid
por: Yang, Ting, et al.
Publicado: (2019)

Prediction of Post-Acute-Sequelae of COVID-19 by Cargo Protein Biomarkers of Blood Total Extracellular Vesicles in Acute COVID-19
por: Goetzl, Edward J., et al.
Publicado: (2023)

Mitochondrial Electron Transport Chain Protein Abnormalities Detected in Plasma Extracellular Vesicles in Alzheimer’s Disease
por: Yao, Pamela J., et al.
Publicado: (2021)

Human tau pathology transmits glial tau aggregates in the absence of neuronal tau
por: Narasimhan, Sneha, et al.
Publicado: (2019)

Extracellular Forms of Aβ and Tau from iPSC Models of Alzheimer’s Disease Disrupt Synaptic Plasticity
por: Hu, Neng-Wei, et al.
Publicado: (2018)

Tau binding protein CAPON induces tau aggregation and neurodegeneration
por: Hashimoto, Shoko, et al.
Publicado: (2019)

Toxic tau: structural origins of tau aggregation in Alzheimer's disease
por: Mamun, Abdullah Al, et al.
Publicado: (2020)

Secreted APP regulates the function of full-length APP in neurite outgrowth through interaction with integrin beta1
por: Young-Pearse, Tracy L, et al.
Publicado: (2008)

Cell models of lipid-rich α-synuclein aggregation validate known modifiers of α-synuclein biology and identify stearoyl-CoA desaturase
por: Imberdis, Thibaut, et al.
Publicado: (2019)

NT1-Tau Is Increased in CSF and Plasma of CJD Patients, and Correlates with Disease Progression
por: Mengel, David, et al.
Publicado: (2021)

Tau Phosphorylation, Aggregation, and Cell Toxicity
por: Avila, J., et al.
Publicado: (2006)

Are Tau Aggregates Toxic or Protective in Tauopathies?
por: Cowan, Catherine M., et al.
Publicado: (2013)

Structure-based inhibitors of tau aggregation
por: Seidler, PM, et al.
Publicado: (2017)

Signature of an aggregation-prone conformation of tau
por: Eschmann, Neil A., et al.
Publicado: (2017)

Pharmacological Modulators of Tau Aggregation and Spreading
por: Dominguez-Meijide, Antonio, et al.
Publicado: (2020)

Bacterial DNA promotes Tau aggregation
por: Tetz, George, et al.
Publicado: (2020)

The Significance of Tau Aggregates in the Human Brain
por: Castellani, Rudy J.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7kcl4d319oja6jsv9lncm2v60m